JP2026500710A5 - - Google Patents

Info

Publication number
JP2026500710A5
JP2026500710A5 JP2025537912A JP2025537912A JP2026500710A5 JP 2026500710 A5 JP2026500710 A5 JP 2026500710A5 JP 2025537912 A JP2025537912 A JP 2025537912A JP 2025537912 A JP2025537912 A JP 2025537912A JP 2026500710 A5 JP2026500710 A5 JP 2026500710A5
Authority
JP
Japan
Prior art keywords
antibody
domain
heterodimer
igg
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025537912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026500710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2023/050681 external-priority patent/WO2024144396A1/en
Publication of JP2026500710A publication Critical patent/JP2026500710A/ja
Publication of JP2026500710A5 publication Critical patent/JP2026500710A5/ja
Pending legal-status Critical Current

Links

JP2025537912A 2022-12-27 2023-12-22 二重特異性タンパク質を製造する方法 Pending JP2026500710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2033843 2022-12-27
NL2033843 2022-12-27
PCT/NL2023/050681 WO2024144396A1 (en) 2022-12-27 2023-12-22 Method for generating bispecific proteins

Publications (2)

Publication Number Publication Date
JP2026500710A JP2026500710A (ja) 2026-01-08
JP2026500710A5 true JP2026500710A5 (cg-RX-API-DMAC7.html) 2026-03-12

Family

ID=85158672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025537912A Pending JP2026500710A (ja) 2022-12-27 2023-12-22 二重特異性タンパク質を製造する方法

Country Status (9)

Country Link
US (1) US20260209390A1 (cg-RX-API-DMAC7.html)
EP (1) EP4642811A1 (cg-RX-API-DMAC7.html)
JP (1) JP2026500710A (cg-RX-API-DMAC7.html)
KR (1) KR20250129720A (cg-RX-API-DMAC7.html)
CN (2) CN121824747A (cg-RX-API-DMAC7.html)
AU (1) AU2023418349A1 (cg-RX-API-DMAC7.html)
IL (1) IL321671A (cg-RX-API-DMAC7.html)
TW (1) TW202432587A (cg-RX-API-DMAC7.html)
WO (1) WO2024144396A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801687A (en) 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
US5151504A (en) 1989-11-17 1992-09-29 E. R. Squibb & Sons, Inc. Method for purification of monoclonal antibodies
PT2560993T (pt) 2010-04-20 2024-09-16 Genmab As Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas
IN2014CN03887A (cg-RX-API-DMAC7.html) * 2011-10-27 2015-10-16 Genmab As
CA3094318A1 (en) 2018-03-30 2019-10-03 Merus N.V. Multivalent antibody
EP3966238A2 (en) 2019-05-09 2022-03-16 Merus N.V. Variant domains for multimerizing proteins and separation thereof
CN116462766A (zh) 2020-05-21 2023-07-21 美勒斯公司 用于生产ig样分子的方法和手段

Similar Documents

Publication Publication Date Title
JP6435193B2 (ja) 抗体を精製する方法
JP2019519492A5 (cg-RX-API-DMAC7.html)
US20230114801A1 (en) MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF
AU2016312909B2 (en) Method for the reduction of host cell proteins in affinity chromatography
JP2021524478A5 (cg-RX-API-DMAC7.html)
US20240092899A1 (en) Bispecific antibody
TWI918721B (zh) Egfr結合複合物及其製備和使用方法
JP7657591B2 (ja) 二重特異性抗原結合コンストラクト
FI4200018T3 (fi) Anti-par-2-vasta-aineet ja niiden käyttömenetelmät
JP2020503873A (ja) 多重特異的抗体を調製するためのポリペプチドリンカー
JP2025508317A5 (cg-RX-API-DMAC7.html)
JP2024516098A5 (cg-RX-API-DMAC7.html)
JP2025505650A5 (cg-RX-API-DMAC7.html)
WO2026012501A1 (zh) 一种抗ngf单克隆抗体及其应用
JP2026508244A (ja) 抗Nectin-4抗体及びそれを含む多重特異性抗体
AU2024275316A1 (en) Ch3 domain variant or bispecific antibody comprising same
JP2024515301A5 (cg-RX-API-DMAC7.html)
JP2024508597A5 (cg-RX-API-DMAC7.html)
JP2024509695A5 (cg-RX-API-DMAC7.html)
IL321671A (en) Method for generating bispecific proteins
KR20250169614A (ko) 최적화된 cd3 항원 결합 도메인
JP2024534853A5 (cg-RX-API-DMAC7.html)
CA3292941A1 (en) Ch3 domain variant or bispecific antibody comprising same
HK40073541A (en) Miniature guidance and navigation control (minignc) antibody-like proteins and methods of making and using thereof